Shares of Hims & Hers Health (NYSE:HIMS) rose in after-hours trading on Tuesday. An SEC Form 4 filing revealed the insider purchase.

Director David B. Wells acquired 48,400 shares of Class A Common Stock. Wells made the open-market purchase on May 26, 2026.

The transaction value totaled approximately $1.17 million. The weighted average price was $24.235 per share.

The acquisition increased Wells' direct holdings in the telehealth company to 224,417 shares. Investors often interpret such board purchases as a vote of confidence in the company's future.